Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,946 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of Clinical Guidelines in Identifying All Japanese Patients with Hereditary Breast and Ovarian Cancer.
Haneda E, Sato A, Suganuma N, Sebata Y, Okamoto S, Toda S, Kohagura K, Matsubara Y, Sugawara Y, Yamanaka T, Yamashita T, Shimizu S, Narimatsu H. Haneda E, et al. Among authors: yamanaka t. Int J Environ Res Public Health. 2022 May 19;19(10):6182. doi: 10.3390/ijerph19106182. Int J Environ Res Public Health. 2022. PMID: 35627717 Free PMC article. Review.
Expression of enhancer of zeste homolog 2 correlates with survival outcome in patients with metastatic breast cancer: exploratory study using primary and paired metastatic lesions.
Inari H, Suganuma N, Kawachi K, Yoshida T, Yamanaka T, Nakamura Y, Yoshihara M, Nakayama H, Yamanaka A, Masudo K, Oshima T, Yokose T, Rino Y, Shimizu S, Miyagi Y, Masuda M. Inari H, et al. Among authors: yamanaka t, yamanaka a. BMC Cancer. 2017 Feb 27;17(1):160. doi: 10.1186/s12885-017-3154-3. BMC Cancer. 2017. PMID: 28241804 Free PMC article.
Clinicopathological and prognostic significance of Ki-67 immunohistochemical expression of distant metastatic lesions in patients with metastatic breast cancer.
Inari H, Suganuma N, Kawachi K, Yoshida T, Yamanaka T, Nakamura Y, Yoshihara M, Nakayama H, Masudo K, Oshima T, Yokose T, Rino Y, Shimizu S, Miyagi Y, Masuda M. Inari H, et al. Among authors: yamanaka t. Breast Cancer. 2017 Nov;24(6):748-755. doi: 10.1007/s12282-017-0774-z. Epub 2017 Apr 19. Breast Cancer. 2017. PMID: 28425014
Non-functioning parathyroid carcinoma: a case report.
Suganuma N, Iwasaki H, Shimizu S, Yoshida T, Yamanaka T, Kojima I, Yamazaki H, Toda S, Nakayama H, Masudo K, Rino Y, Kawachi K, Miyagi Y, Miyake A, Ohashi K, Masuda M. Suganuma N, et al. Among authors: yamanaka t. Surg Case Rep. 2017 Dec;3(1):81. doi: 10.1186/s40792-017-0357-4. Epub 2017 Jul 19. Surg Case Rep. 2017. PMID: 28726134 Free PMC article.
Potential Risk Factors for Nivolumab-induced Thyroid Dysfunction.
Yamazaki H, Iwasaki H, Yamashita T, Yoshida T, Suganuma N, Yamanaka T, Masudo K, Nakayama H, Kohagura K, Rino Y, Masuda M. Yamazaki H, et al. Among authors: yamanaka t. In Vivo. 2017 Nov-Dec;31(6):1225-1228. doi: 10.21873/invivo.11195. In Vivo. 2017. PMID: 29102951 Free PMC article.
1,946 results